| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.AJOG.2003.09.073 |
| P698 | PubMed publication ID | 15118638 |
| P50 | author | Siegal Sadetzki | Q30527442 |
| Angela Chetrit | Q47460871 | ||
| P2093 | author name string | Marek Glezerman | |
| Joseph Menczer | |||
| Benjamin Piura | |||
| National Israel Ovarian Cancer Group | |||
| Baruch Modan | |||
| Giulia Barda | |||
| F Lubin | |||
| Dani Beck | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian carcinoma | Q18556145 |
| P304 | page(s) | 1039-1045 | |
| P577 | publication date | 2004-04-01 | |
| P1433 | published in | American Journal of Obstetrics and Gynecology | Q4744256 |
| P1476 | title | Comparison between primary peritoneal and epithelial ovarian carcinoma: a population-based study | |
| P478 | volume | 190 |
| Q81299131 | Additional salpingectomy after previous prophylactic oophorectomy in high-risk women: sense or nonsense? |
| Q34528553 | Adenocarcinoma of Mullerian origin: review of pathogenesis, molecular biology, and emerging treatment paradigms. |
| Q37336360 | Clinical characteristics of primary peritoneal carcinoma |
| Q59238332 | Colonic or coelomic? |
| Q37252742 | Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995-2004. |
| Q83597688 | Low-grade serous primary peritoneal carcinoma |
| Q34586019 | Multiple genetic alterations within the PI3K pathway are responsible for AKT activation in patients with ovarian carcinoma |
| Q24234923 | Optimal primary surgical treatment for advanced epithelial ovarian cancer |
| Q34998994 | Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems |
| Q37298929 | PIK3CA alterations in Middle Eastern ovarian cancers |
| Q47189965 | Peritoneal carcinomatosis after risk-reducing surgery in BRCA1/2 mutation carriers. |
| Q34803840 | Potentially important microRNA cluster on chromosome 17p13.1 in primary peritoneal carcinoma |
| Q36587222 | Primary peritoneal adenocarcinoma as content of an incarcerated umbilical hernia: A case-report and review of the literature |
| Q81401953 | Primary peritoneal carcinoma--Uterine involvement and hysterectomy |
| Q51168514 | Primary peritoneal clear cell carcinoma treated with IMRT and interstitial HDR brachytherapy: a case report. |
| Q34371477 | REDD1 and p-AKT over-expression may predict poor prognosis in ovarian cancer |
| Q37295240 | Rapidly increasing incidence of papillary serous carcinoma of the peritoneum in the United States: fact or artifact? |
| Q92433727 | Serous adenocarcinoma of retroperitoneum: a case report |
| Q38330192 | Serous ovarian, fallopian tube and primary peritoneal cancers: a common disease or separate entities - a systematic review. |
| Q37125079 | Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention |
| Q80489408 | Time for action: a "sea change" in treatment strategies for rare types of epithelial ovarian cancer |
| Q38602517 | Tissue glycomics distinguish tumour sites in women with advanced serous adenocarcinoma |
| Q37626455 | Tumorgrafts as in vivo surrogates for women with ovarian cancer. |
Search more.